8-K - Dermata Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 27, 2026, Dermata Therapeutics, Inc. (the “Company”) filed a prospectus supplement (the “Current Prospectus Supplement”) to increase th

Other Event

$705.0K$3.5M$705.0K

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Lowenstein Sandler LLP 23.1 Consent of Lowenstein Sandler LLP (included

Exhibits Only

Exhibits (2)

5.1

EX-5.1

8-K